NEMO/IKKγ: Linking NF-κB to human disease

Trends in Molecular Medicine

Volumn 7, Issue 10, 2001, Pages 427-430

  Courtois, Gilles ^a   Smahi, Asma ^b   Israël, Alain ^a  

^a INSTITUT PASTEUR   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B; I KAPPA B KINASE; I KAPPA B KINASE GAMMA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHOTRANSFERASE; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ANHIDROTIC ECTODERMAL DYSPLASIA; APOPTOSIS; CHROMOSOME XQ; GENE MUTATION; HOMEOSTASIS; HUMAN; IMMUNE DEFICIENCY; INCONTINENTIA PIGMENTI; NONHUMAN; PROTEIN DOMAIN; REVIEW; X CHROMOSOME LINKED DISORDER;

EID: 0034798380     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4914(01)02154-2     Document Type: Review

References (38)

1. Phosphorylation meets ubiquitination: The control of NF-κB activity
2. The IKK complex: An integrator of all signals that activate NF-κB?
3. Complementation cloning of NEMO, a component of the IkB kinase complex essential for NF-κB activation
4. IKKγ is an essential regulatory subunit of the IkB kinase complex
5. IκB kinase (IKK)-associated protein 1, a common component of the heterogenous IKK complex
6. Isolation of full-length cDNA and chromosomal localization of human NF-kappaB modulator NEMO to Xq28
7. Incontinentia pigmenti (Bloch-Sulzberger syndrome)
8. Genomic rearrangement in NEMO impairs NF-κB activation and is a cause of incontinentia pigmenti
9. Female mice heterozygous for IKKγ/NEMO deficiencies develop a dermatopathy similar to the human X-linked disorder incontinentia pigmenti
10. Severe liver degeneration and lack of NF-κB activation in NEMO/IKKγ-deficient mice
11. NEMO/IKKγ deficient mice model incontinentia pigmenti
12. Genetic approaches in mice to understand Rel/NF-κB and IκB function
13. Absence of tumor necrosis factor rescues RelA-deficient mice from embryonic lethality
14. Severe liver degeneration in mice lacking the IkappaB kinase 2 gene
15. A novel X-linked disorder of immune deficiency and hypohidrotic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutations in IKKγ(NEMO)
16. Atypical forms of incontinentia pigmenti in male individuals result from mutations of a cytosine tract in exon 10 of NEMO (IKK-γ)
17. X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-κB signaling
18. Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia
19. Ectodermal dysplasia: A clinical classification and a causal review
20. X-linked anhidrotic (hypohidrotic) ectodermal dysplasia is caused by mutation in a novel transmembrane protein
21. The gene defective in anhidrotic ectodermal dysplasia is expressed in the developing epithelium, neuroectoderm, thymus and bone
22. Ectodysplasin is a collagenous trimeric type II membrane protein with a tumour necrosis factor-like domain and co-localizes with cytoskeletal structures at lateral and apical surfaces of cells
23. Ectodysplasin, a protein required for epithelial morphogenesis, is a novel TNF homologue and promotes cell-matrix adhesion
24. Mutations leading to X-linked hypohidrotic ectodermal dysplasia affect three major functional domains in the TNF family member EDA
25. Ectodysplasin is released by proteolytic shedding and binds to the EDAR protein
26. Mutations within a furin consensus sequence block proteolytic release of ectodysplasin and cause X-linked hypohidrotic ectodermal dysplasia
27. Mutations in the human homologue of mouse dl cause autosomal recessive and dominant hypohidrotic ectodermal dysplasia
28. Involvement of a novel TNF receptor homologue in hair follicle induction
29. Ectodermal dysplasia receptor activates the nuclear factor κB, c-Jun N-terminal kinase and cell death pathways and binds to ectodysplasin A
30. Two-amino acid molecular switch in an epithelial morphogen that regulates binding to two distincts receptors
31. Edar/Eda interactions regulate enamel knot formation in tooth morphogenesis
32. TNF signaling via the ligand-receptor pair ectodysplasin and edar controls the function of epithelia signaling centers and is regulated by Wnt and activin during tooth organogenesis
33. Incontinentia pigmenti in a newborn male infant with DNA confirmation
34. Incontinentia pigmenti in a surviving male is accompanied by hypohidrotic ectodermal dysplasia and recurrent infection
35. Requirement for NF-κB in osteoclast and B-cell development
36. Osteopetrosis in mice lacking NF-κb1 and NF-κb2
37. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand
38. Missense mutations interfere with VEGFR-3 signaling in primary lymphoedema